Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the p

IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.03) per share which missed the analyst consen

Phase 2 topline readout expected in Q4 2026 following patient follow-up, database lock, and unblindi

POTOMAC, MD / ACCESS Newswire / August 11, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the

POTOMAC, MD / ACCESS Newswire / July 29, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "

Seven presentations highlight patent-pending agentic automation, speech-based cognitive models, EHR

Senior management elects restricted common stock at $0.27 per share in lieu of repayment of amounts

Senior management elects restricted common stock at $0.27 per share in lieu of repayment of amounts

Patent-Pending Multi-Agent Architecture Targets Fragmented Biomedical Data and Expands Toward Imagin

Patent-Pending Multi-Agent Architecture Targets Fragmented Biomedical Data and Expands Toward Imagin

Company Continuing Limited Over-Enrollment Activities to Account for Attrition and Support Robust Mo

POTOMAC, MD / ACCESS Newswire / June 9, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "C

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the p

https://www.marijuanamoment.net/white-house-pushes-congress-to-keep-hemp-cbd-products-legal-by-amend

Approximately 80% of target participants have completed trial participation, strengthening momentum

Approximately 80% of target participants have completed trial participation, strengthening momentum

https://www.marijuanamoment.net/marijuana-components-have-consistent-anti-tumor-effec

- Continued Advancement of CALMA Phase 2 Trial - POTOMAC, MD / ACCESS Newswire / May 19, 2026 / IGC

Research highlights advanced imaging analytics that may support Alzheimer's disease monitoring, pati

Outreach initiative supports awareness of agitation and patient engagement as enrollment approaches

https://apnews.com/article/medical-marijuana-rescheduling-justice-department-trump-cannabis-1d6722d3

https://www.axios.com/2026/04/22/trump-marijuana-rule-change

Behavioral neurology expertise and expanded patient access support final phase of recruitment in Alz

Behavioral neurology expertise and expanded patient access support final phase of recruitment in Alz

Authorization provides regulated capability to evaluate emerging therapeutic approaches alongside Ph

Authorization provides regulated capability to evaluate emerging therapeutic approaches alongside Ph

IGC Pharma, Inc. (NYSE:IGC) ("IGC" or the "Company") today announced that it has app

POTOMAC, MD / ACCESS Newswire / April 14, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the

POTOMAC, MD / ACCESS Newswire / April 8, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the p

POTOMAC, MD / ACCESS Newswire / April 7, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "

POTOMAC, MD / ACCESS Newswire / March 30, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the

https://cannabiswire.com/newsletters/scoop-medicare-cbd-pilot-will-allow-some-thc-in-products/?free_

IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.01) per share which beat the analyst consensu

- Strategic Pivot to Pure-Play Biotech - POTOMAC, MD / ACCESS Newswire / March 19, 2026 / IGC Pharma

IGC Pharma, Inc. (NYSEAMERICAN:IGC - Get Free Report) was the recipient of a large increase in short

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the p

https://www.marijuanamoment.net/federal-agency-finalized-rule-for-cbd-medicare-coverage-pilot-progra

https://www.marijuanamoment.net/gop-congressman-isnt-sure-marijuana-rescheduling-is-a-doj-priority-b

IGC Pharma, Inc. (NYSE:IGC) ("IGC" or the "Company"), a clinical-stage pharmaceutica

IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage phar

https://www.marijuanamoment.net/new-hampshire-house-passes-bills-to-legalize-marijuana-and-let-dispe

https://www.marijuanamoment.net/congressional-leaders-drop-attempt-to-block-marijuana-rescheduling-w

https://www.marijuanamoment.net/florida-attorney-general-asks-supreme-court-to-block-marijuana-legal

https://www.marijuanamoment.net/federal-health-programs-will-cover-up-to-500-worth-of-cbd-for-certai

https://themarijuanaherald.com/2025/12/president-trump-directs-attorney-general-pam-bondi-to-finaliz

https://www.marijuanamoment.net/supreme-court-should-uphold-gun-ban-for-marijuana-users-19-state-ags

IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biot